Disclaimer: This page is provided for educational and documentation purposes only. It reflects the personal protocol I follow based on my own research and situation. It is not medical advice, a diagnosis, or a treatment plan for anyone else. Always consult a qualified healthcare professional before making any changes to your diet, supplements, or medications. Results and experiences vary.
Overview
This page summarizes the personal metabolic protocol I follow as part of a comprehensive, research-driven approach to managing health. My focus is on maintaining therapeutic ketosis, supporting mitochondrial function, and limiting major tumor fuels such as glucose and glutamine.
I share this information for transparency and education — not as medical advice or a treatment plan. Everyone’s biology and medical situation are unique, so what works for me may not apply to others. I encourage anyone interested in similar strategies to work closely with a qualified healthcare professional.
Purpose
The goal of this protocol is to document the off-label and supplemental metabolic approach I personally follow. It focuses on therapeutic compounds, scheduling, and metabolic targeting.
Daily Schedule
| Time | Focus | Notes |
|---|---|---|
| 6:00 AM | Hydrate | Water with electrolytes upon waking |
| 7:15 AM | Iron and Artemisinin | With bulletproof coffee, I take Chelated Iron (27 mg), wait about 15 minutes, then take Artemisinin (1000 mg). This spacing is my personal routine to improve tolerance and absorption. |
| 7:30 AM | Morning Stack | (per schedule below) Ivermectin/Fenbendazole, Mebendazole on alternating days. Ivermectin is taken with MCT coffee; Fenbendazole and Mebendazole are taken with a fatty breakfast. |
Supplements & Compounds (Personal Use Record)
This section documents what I personally use. It is not a recommendation for others.
Artemisinin 1000 mg (taken ~15 minutes after Chelated Iron 27 mg)
Ivermectin 30 mg — Mon/Wed/Fri (w/ bulletproof coffee)
Fenbendazole 444 mg — Mon/Wed/Fri (w/ high-fat breakfast)
Mebendazole 400 mg — Tues/Thurs/Sat (w/ high-fat breakfast)
(With second high-fat meal)
MCS Formulas: Glutamine Inhibifour, Glycolysis Inhibithree, Genistein Ultra
Betulinic Acid 100 mg, EGCG 800 mg, Berberine 1000 mg
5-LOX Inhibitor, Silymarin, Thymoquinone Extract, Beta-Glucans Mushroom Extracts
Vitamins: C (2000 mg), B-Complex (50 mg), D3 (5000 IU with K2)
AprésFlex® (Boswellia serrata 20% AKBA) — 2 capsules daily
Prostate Support: Life Extension Ultra Prostate Formula; Swanson, Lyc-O-Mato Lycopene, 40 mg
All items listed above are self-purchased and non-sponsored. I have no affiliations with manufacturers or distributors.
Where to Order
Listed below are publicly available sources for the same over-the-counter or veterinary formulations I personally use. This is for documentation only — not an endorsement or medical recommendation.
✦ Fenbendazole (Joe Tippens Protocol, one 2g packet = 444mg)
https://www.amazon.com/dp/B00028ZLDG
✦ Mebendazole
https://allfamilypharmacy.com/ivermectin/
✦ Ivermectin
https://allfamilypharmacy.com/ivermectin/
Important Notice
This protocol represents my personal approach and ongoing self-experiment. It may not be safe or appropriate for others. Use of any substances described is at your own risk and should only be undertaken under professional supervision.
References
- Seyfried TN. Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. Wiley; 2012.
- Seyfried TN, Shelton LM. “Cancer as a metabolic disease.” Nutr Metab (Lond). 2010; 7:7.
- DeBerardinis RJ, Chandel NS. “Fundamentals of cancer metabolism.” Sci Adv. 2016; 2(5):e1600200.
- Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. “Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells.” J Cell Biol. 2007; 178(1):93–105.
- Vander Heiden MG, Cantley LC, Thompson CB. “Understanding the Warburg effect: the metabolic requirements of cell proliferation.” Science. 2009; 324(5930):1029–1033.
- Poff AM, Ari C, Seyfried TN, D’Agostino DP. “The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.” PLoS One. 2013; 8(6):e65522.
- Klement RJ, Champ CE. “Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R’s through dietary manipulation.” Cancer Metastasis Rev. 2014; 33(1):217–229.
- Martínez-Outschoorn UE, Peiris-Pagés M, Pestell RG, Sotgia F, Lisanti MP. “Cancer metabolism: a therapeutic perspective.” Nat Rev Clin Oncol. 2017; 14(1):11–31.
- Veech RL. “The therapeutic implications of ketone bodies: effects in pathological conditions, ketosis, ketogenic diet, and mitochondrial metabolism.” Prostaglandins Leukot Essent Fatty Acids. 2004; 70(3):309–319.
- Pearson K, et al. “Targeting metabolism in cancer therapy: the roles of ketogenic diets and glutamine inhibition.” Front Oncol. 2021; 11:673657.
For privacy and legal terms, see: Privacy Policy & Terms of Use.
Cancer as a Metabolic Journey: Exploring an Alternative Therapy 